Nuclein

Austin, United States

Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.

$19.1M raised

Oct 2025

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Nuclein raised?

Nuclein has raised $19.1M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2025.

Who are Nuclein's investors?

Nuclein's investors include Trinity Investors, Trinity Private Equity Group.

Where is Nuclein headquartered?

Nuclein is headquartered in Austin, United States.

What does Nuclein do?

Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.

What stage is Nuclein at?

Nuclein is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 14, 2025.

MLA

"Nuclein — Funding & Investors." VCBacked, October 14, 2025, https://www.vcbacked.co/company/nuclein. Accessed July 4, 2026.

APA

VCBacked. (2025). Nuclein — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/nuclein

Wikipedia (cite web)

{{cite web |title=Nuclein — Funding & Investors |url=https://www.vcbacked.co/company/nuclein |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 14, 2025.